Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma

Journal of Lipid Research

Volumn 51, Issue 6, 2010, Pages 1416-1423

  Wood, JodiAnne T ^a   Williams, John S ^a   Pandarinathan, Lakshmipathi ^a   Janero, David R ^a   Lammi Keefe, Carol J ^b   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

2 arachidonoylglycerol; Anandamide; Lipidomics; Metabolomics; Mouse; Nutritional fatty acid supplementation; Omega 3 fatty acids

Indexed keywords

2 EICOSAPENTANOYLGLYCEROL; DOCOSAHEXAENOIC ACID; DOCOSAHEXANOYLETHANOLAMINE; ENDOCANNABINOID; ETHANOLAMINE; GLYCEROL; ICOSAPENTAENOIC ACID; N ACYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; LIPIDOMICS; MALE; METABOLOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; BRAIN; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; ENDOCANNABINOIDS; ETHANOLAMINES; FATTY ACIDS, UNSATURATED; GLYCEROL; LIPID METABOLISM; MALE; METABOLOME; MICE; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 77952738210     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M002436     Document Type: Article

References (61)

1. De Petrocellis, L., and V. Di Marzo. 2009. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract. Res. Clin. Endocrinol. Metab. 23: 1-15.
2. Kano, M., T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe. 2009. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89: 309-380.
3. Hwang, J., C. Adamson, D. Butler, D. R. Janero, A. Makriyannis, and B. A. Bahr. 2010. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. Life Sci. 86: 615-623.
4. Bradshaw, H. B., and J. M. Walker. 2005. The expanding field of cannabimimetic and related lipid mediators. Br. J. Pharmacol. 144: 459-465.
5. Karanian, D. A., Q. B. Brown, A. Makriyannis, T. A. Kosten, and B. A. Bahr. 2005. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. J. Neurosci. 25: 7813-7820.
6. Panikashvili, D., C. Simeonidou, S. Ben-Shabat, L. Hanus, A. Breuer, R. Mechoulam, and E. Shohami. 2001. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 413: 527-531. (Pubitemid 32938751)
7. Sheskin, T., L. Hanus, J. Slager, Z. Vogel, and R. Mechoulam. 1997. Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40: 659-667. (Pubitemid 27102571)
8. Williams, J., L. Pandarinathan, J. Wood, P. Vouros, and A. Makriyannis. 2006. Endocannabinoid metabolomics: a novel liquid chromatography-mass spectrometry reagent for fatty acid analysis. AAPS J. 8: E655-E660. (Pubitemid 44752475)
9. Kingsley, P. J., and L. J. Marnett. 2009. Analysis of endocannabinoids, their congeners and COX-2 metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2746-2754.
10. Janero, D. R., and A. Makriyannis. 2009. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin. Emerg. Drugs. 14: 43-65.
11. Ligresti, A., S. Petrosino, and V. Di Marzo. 2009. From endocannabinoid profiling to 'endocannabinoid therapeutics'. Curr. Opin. Chem. Biol. 13: 321-331.
12. Artmann, A., G. Petersen, L. I. Hellgren, J. Boberg, C. Skonberg, C. Nellemann, S. H. Hansen, and H. S. Hansen. 2008. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta. 1781: 200-212.
13. Astorg, P., S. Bertrais, F. Laporte, N. Arnault, C. Estaquio, P. Galan, A. Favier, and S. Hercberg. 2008. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Eur. J. Clin. Nutr. 62: 1155-1161.
14. Hadders-Algra, M. 2008. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 36: 101-109. (Pubitemid 351364313)
15. Borrelli, F., and A. A. Izzo. 2009. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract. Res. Clin. Endocrinol. Metab. 23: 33-49.
16. Connor, W. E., M. Neuringer, and D. S. Lin. 1990. Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J. Lipid Res. 31: 237-247
17. Wainwright, P. E., H. C. Xing, L. Mutsaers, D. McCutcheon, and D. Kyle. 1997. Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. J. Nutr. 127: 184-193.
18. Chen, C. T., J. T. Green, S. K. Orr, and R. P. Bazinet. 2008. Regulation of brain polyunsaturated fatty acid uptake and turn-over. Prostaglandins Leukot. Essent. Fatty Acids. 79: 85-91.
19. Brenna, J. T., and G. Y. Diau. 2007. The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids. 77: 247-250.
20. Rapoport, S. I., J. S. Rao, and M. Igarashi. 2007. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fatty Acids. 77: 251-261. (Pubitemid 350214520)
21. Bourre, J. M. 2007. Dietary omega-3 fatty acids for women. Biomed. Pharmacother. 61: 105-112. (Pubitemid 46578282)
22. Horrocks, L. A., and Y. K. Yeo. 1999. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40: 211-225. (Pubitemid 29435720)
23. Rapoport, S. I. 2008. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids. 79: 153-156.
24. Watanabe, S., M. Doshi, and T. Hamazaki. 2003. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot. Essent. Fatty Acids. 69: 51-59. (Pubitemid 37421501)
25. Harris, W. S., P. M. Kris-Etherton, and K. A. Harris. 2008. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr. Atheroscler. Rep. 10: 503-509.
26. Wurtman, R. J. 2008. Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents. Metabolism. 57 ( Suppl. 2 ): S6-S10.
27. Simopoulos, A. P. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood). 233: 674-688.
28. Adibhatla, R. M., and J. F. Hatcher. 2008. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 49: 241-268.
29. Hill, M. N., G. E. Miller, W. S. Ho, B. B. Gorzalka, and C. J. Hillard. 2008. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 41: 48-53.
30. Khanapure, S. P., D. S. Garvey, D. R. Janero, and L. G. Letts. 2007. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem. 7: 311-340.
31. Berger, A., G. Crozier, T. Bisogno, P. Cavaliere, S. Innis, and V. DiMarzo. 2001. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc. Natl. Acad. Sci. USA. 98: 6402-6406. (Pubitemid 32488249)
32. Lim, S., and H. Suzuki. 2001. Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J. Nutr. 131: 319-324. (Pubitemid 32115375)
33. Buczynski, M. W., D. S. Dumlao, and E. A. Dennis. 2009. Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid Res. 50: 1015-1038.
34. Monteleone, P., I. Matias, V. Martiadis, L. D. Petrocellis, M. Maj, and V. Di Marzo. 2005. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology. 30: 1216-1221.
35. Wood, J. T., J. S. Williams, L. Pandarinathan, A. Courville, M. R. Keplinger, D. R. Janero, P. Vouros, A. Makriyannis, and C. J. Lammi-Keefe. 2008. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters. Clin. Chem. Lab. Med. 46: 1289-1295.
36. Williams, J., J. Wood, L. Pandarinathan, D. A. Karanian, B. A. Bahr, P. Vouros, and A. Makriyannis. 2007. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal. Chem. 79: 5582-5593. (Pubitemid 47229803)
37. Griffiths, W. J., and Y. Wang. 2009. Mass spectrometry: from proteomics to metabolomics and lipidomics. Chem. Soc. Rev. 38: 1882-1896.
38. Astarita, G., J. Geaga, F. Ahmed, and D. Piomelli. 2009. Targeted lipidomics as a tool to investigate endocannabinoid function. Int. Rev. Neurobiol. 85: 35-55.
39. Bradshaw, H. B., N. Rimmerman, S. S. Hu, S. Burstein, and J. M. Walker. 2009. Novel endogenous N-acyl glycines identification and characterization. Vitam. Horm. 81: 191-205.
40. Astarita, G., F. Ahmed, and D. Piomelli. 2008. Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. J. Lipid Res. 49: 48-57.
41. King, S. S., A. A. Abughazaleh, S. K. Webel, and K. L. Jones. 2008. Circulating fatty acid profiles in response to three levels of dietary omega-3 fatty acid supplementation in horses. J. Anim. Sci. 86: 1114-1123.
42. Guijarro, A., J. Fu, G. Astarita, and D. Piomelli. 2009. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice. Pharmacol Res. 61: 27-33.
43. Mebarek, S., N. Ermak, A. Benzaria, S. Vicca, M. Dubois, G. Nemoz, M. Laville, B. Lacour, E. Vericel, M. Lagarde, et al. 2009. Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis. Br. J. Nutr. 101: 852-858.
44. Gronn, M., E. Christensen, T. A. Hagve, and B. O. Christophersen. 1991. Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells. Biochim. Biophys. Acta. 1081: 85-91.
45. Chen, C. T., Z. Liu, M. Ouellet, F. Calon, and R. P. Bazinet. 2009. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot. Essent. Fatty Acids. 80: 157-163.
46. Matias, I., G. Carta, E. Murru, S. Petrosino, S. Banni, and V. Di Marzo. 2008. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim. Biophys. Acta. 1781: 52-60.
47. Batetta, B., M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. Bisogno, S. Uda, et al. 2009. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J. Nutr. 139: 1495-1501.
48. Madsen, L., A. C. Rustan, H. Vaagenes, K. Berge, E. Dyroy, and R. K. Berge. 1999. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids. 34: 951-963. (Pubitemid 29493756)
49. Polozova, A., E. Gionfriddo, and N. Salem, Jr. 2006. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins Leukot. Essent. Fatty Acids. 75: 183-190. (Pubitemid 44292522)
50. Emken, E. A., R. O. Adlof, W. K. Rohwedder, and R. M. Gulley. 1993. Influence of linoleic acid on desaturation and uptake of deuterium-labeled palmitic and stearic acids in humans. Biochim. Biophys. Acta. 1170: 173-181.
51. Emken, E. A., R. O. Adlof, S. M. Duval, and G. J. Nelson. 1999. Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids. 34: 785-791.
52. Fu, J., J. Kim, F. Oveisi, G. Astarita, and D. Piomelli. 2008. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295: R45-R50.
53. Thabuis, C., D. Tissot-Favre, J. B. Bezelgues, J. C. Martin, C. Cruz-Hernandez, F. Dionisi, and F. Destaillats. 2008. Biological functions and metabolism of oleoylethanolamide. Lipids. 43: 887-894.
54. Schwartz, G. J., J. Fu, G. Astarita, X. Li, S. Gaetani, P. Campolongo, V. Cuomo, and D. Piomelli. 2008. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 8: 281-288.
55. Kirkham, T. C., and S. A. Tucci. 2006. Endocannabinoids in appetite control and the treatment of obesity. CNS Neurol. Disord. Drug Targets. 5: 272-292.
56. Magni, P., E. Dozio, M. Ruscica, F. Celotti, M. A. Masini, P. Prato, M. Broccoli, A. Mambro, M. More, and F. Strollo. 2009. Feeding behavior in mammals including humans. Ann. N. Y. Acad. Sci. 1163: 221-232.
57. Cote, M., I. Matias, I. Lemieux, S. Petrosino, N. Almeras, J. P. Despres, and V. Di Marzo. 2007. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond). 31: 692-699.
58. Ruby, M. A., D. K. Nomura, C. S. Hudak, L. M. Mangravite, S. Chiu, J. E. Casida, and R. M. Krauss. 2008. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc. Natl. Acad. Sci. USA. 105: 14561-14566.
59. Arai, T., H. J. Kim, H. Chiba, and A. Matsumoto. 2009. Interaction of fenofibrate and fish oil in relation to lipid metabolism in mice. J. Atheroscler. Thromb. 16: 283-291.
60. Higuchi, T., N. Shirai, and H. Suzuki. 2006. Effects of dietary herring roe lipids on plasma lipid, glucose, insulin, and adiponectin concentrations in mice. J. Agric. Food Chem. 54: 3750-3755. (Pubitemid 43844210)
61. Higuchi, T., N. Shirai, and H. Suzuki. 2006. Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets. Ann. Nutr. Metab. 50: 147-154. (Pubitemid 43325911)